Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NCBP1 | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of NCBP1 mRNA | CTD | PMID:23649840 | NCBP1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NCBP1 mRNA | CTD | PMID:22206623 | NCBP1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Ncbp1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | NCBP1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | NCBP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases phosphorylation | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased phosphorylation of NCBP1 protein | CTD | PMID:23298284 | NCBP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NCBP1 mRNA | CTD | PMID:33387578 | NCBP1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of NCBP1 mRNA | CTD | PMID:21346803 | NCBP1 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of NCBP1 mRNA | CTD | PMID:30851411 | NCBP1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of NCBP1 mRNA | CTD | PMID:21179406 | NCBP1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of NCBP1 mRNA | CTD | PMID:30047161 | NCBP1 | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of NCBP1 protein | CTD | PMID:38460933 | NCBP1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NCBP1 gene | CTD | PMID:27153756 | NCBP1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of NCBP1 mRNA | CTD | PMID:23724009 | NCBP1 | Human | amitrole | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of NCBP1 mRNA | CTD | PMID:30047161 | NCBP1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of NCBP1 mRNA | CTD | PMID:33212167 | NCBP1 | Human | benzatropine | decreases expression | EXP | | 6480464 | Benztropine results in decreased expression of NCBP1 protein | CTD | PMID:34122009 | NCBP1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NCBP1 intron | CTD | PMID:30157460 | NCBP1 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NCBP1 intron | CTD | PMID:30157460 | NCBP1 | Human | bisphenol A | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NCBP1 mRNA | CTD | PMID:25181051 | NCBP1 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NCBP1 gene | CTD | PMID:31601247 | NCBP1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NCBP1 mRNA and bisphenol A results in decreased expression of NCBP1 protein | CTD | PMID:29275510 and PMID:37567409 | NCBP1 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of NCBP1 protein | CTD | PMID:34186270 | NCBP1 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of NCBP1 protein | CTD | PMID:34186270 | NCBP1 | Human | carbon nanotube | increases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of NCBP1 mRNA | CTD | PMID:25554681 | NCBP1 | Human | chlorpyrifos | decreases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NCBP1 mRNA | CTD | PMID:37019170 | NCBP1 | Human | chromium(6+) | affects expression | ISO | Ncbp1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of NCBP1 mRNA | CTD | PMID:28472532 | NCBP1 | Human | clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of NCBP1 protein | CTD | PMID:34122009 | NCBP1 | Human | cocaine | affects expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Cocaine affects the expression of NCBP1 mRNA | CTD | PMID:20187946 | NCBP1 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of NCBP1 mRNA | CTD | PMID:19167446 | NCBP1 | Human | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of NCBP1 protein | CTD | PMID:34122009 | NCBP1 | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of NCBP1 mRNA | CTD | PMID:38568856 | NCBP1 | Human | dibenzo[a,l]pyrene | decreases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in decreased expression of NCBP1 mRNA | CTD | PMID:25908611 | NCBP1 | Human | dibutyl phthalate | decreases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of NCBP1 mRNA | CTD | PMID:17361019 and PMID:21266533 | NCBP1 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NCBP1 protein | CTD | PMID:23301498 | NCBP1 | Human | ethanol | affects splicing | ISO | Ncbp1 (Mus musculus) | 6480464 | Ethanol affects the splicing of NCBP1 mRNA | CTD | PMID:30319688 | NCBP1 | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of NCBP1 mRNA | CTD | PMID:23649840 | NCBP1 | Human | flutamide | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of NCBP1 mRNA | CTD | PMID:24136188 | NCBP1 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of NCBP1 mRNA | CTD | PMID:23649840 | NCBP1 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of NCBP1 protein | CTD | PMID:37730182 | NCBP1 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NCBP1 gene | CTD | PMID:31601247 | NCBP1 | Human | gemcitabine | increases expression | EXP | | 6480464 | Gemcitabine results in increased expression of NCBP1 mRNA | CTD | PMID:17039268 | NCBP1 | Human | gentamycin | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of NCBP1 mRNA | CTD | PMID:22061828 | NCBP1 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of NCBP1 mRNA | CTD | PMID:20044591 | NCBP1 | Human | inulin | multiple interactions | ISO | Ncbp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NCBP1 mRNA | CTD | PMID:36331819 | NCBP1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of NCBP1 protein | CTD | PMID:32959892 | NCBP1 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of NCBP1 mRNA | CTD | PMID:28903495 | NCBP1 | Human | mercury dichloride | decreases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Mercuric Chloride results in decreased expression of NCBP1 mRNA | CTD | PMID:16507785 | NCBP1 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NCBP1 intron | CTD | PMID:30157460 | NCBP1 | Human | methimazole | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of NCBP1 mRNA | CTD | PMID:30047161 | NCBP1 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of NCBP1 mRNA | CTD | PMID:23649840 | NCBP1 | Human | nefazodone | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of NCBP1 mRNA | CTD | PMID:24136188 | NCBP1 | Human | Nutlin-3 | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of NCBP1 protein | CTD | PMID:38460933 | NCBP1 | Human | ochratoxin A | decreases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased expression of NCBP1 mRNA | CTD | PMID:18417182 | NCBP1 | Human | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of NCBP1 mRNA | CTD | PMID:17762391 | NCBP1 | Human | oxaliplatin | multiple interactions | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NCBP1 mRNA | CTD | PMID:25729387 | NCBP1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ncbp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NCBP1 mRNA | CTD | PMID:36331819 | NCBP1 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of NCBP1 mRNA | CTD | PMID:30851411 | NCBP1 | Human | resveratrol | decreases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | resveratrol results in decreased expression of NCBP1 protein | CTD | PMID:25505154 | NCBP1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of NCBP1 mRNA | CTD | PMID:23557933 | NCBP1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NCBP1 mRNA | CTD | PMID:38568856 | NCBP1 | Human | sodium arsenite | increases activity | EXP | | 6480464 | sodium arsenite results in increased activity of NCBP1 protein | CTD | PMID:30528433 | NCBP1 | Human | sulfadimethoxine | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of NCBP1 mRNA | CTD | PMID:30047161 | NCBP1 | Human | tetrachloromethane | increases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NCBP1 mRNA | CTD | PMID:27339419 and PMID:31919559 | NCBP1 | Human | tetrachloromethane | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of NCBP1 mRNA | CTD | PMID:31150632 | NCBP1 | Human | thioacetamide | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of NCBP1 mRNA | CTD | PMID:34492290 | NCBP1 | Human | topotecan | multiple interactions | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NCBP1 mRNA | CTD | PMID:25729387 | NCBP1 | Human | Tributyltin oxide | decreases phosphorylation | ISO | Ncbp1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased phosphorylation of NCBP1 protein | CTD | PMID:22174045 | NCBP1 | Human | trichloroethene | decreases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of NCBP1 mRNA | CTD | PMID:33387578 | NCBP1 | Human | trimellitic anhydride | increases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of NCBP1 mRNA | CTD | PMID:19042947 | NCBP1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of NCBP1 mRNA | CTD | PMID:37042841 | NCBP1 | Human | Triptolide | increases expression | ISO | Ncbp1 (Mus musculus) | 6480464 | triptolide results in increased expression of NCBP1 mRNA | CTD | PMID:32835833 | NCBP1 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of NCBP1 mRNA | CTD | PMID:28818685 | NCBP1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of NCBP1 gene | CTD | PMID:29154799 | NCBP1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NCBP1 mRNA | CTD | PMID:23179753 | NCBP1 | Human | vinclozolin | increases expression | ISO | Ncbp1 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of NCBP1 mRNA | CTD | PMID:23034163 | NCBP1 | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of NCBP1 mRNA | CTD | PMID:23649840 | NCBP1 | Human | Yessotoxin | decreases expression | EXP | | 6480464 | yessotoxin analog results in decreased expression of NCBP1 mRNA | CTD | PMID:30679557 | |